Companies with a Value score of at least 3, ordered by Value score

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
ARYN	CHF 54.00	-4.8%	-34.7%	CHF 1.3b	CHF 74.17	13.8	8.7%	0%	Food, Beverage & Tobacco
HEID	CHF 171.15	0%	-5.6%	CHF 29.1b	CHF 231.33	14.6	9.7%	2.2%	Materials
FORN	CHF 735.00	-0.5%	-11.9%	CHF 1.0b	CHF 893.33	15.1	11.8%	3.4%	Capital Goods
PFE	CHF 19.35	-2.4%	n/a	CHF 137.2b	CHF 23.62	18.2	-1.8%	7.2%	Pharmaceuticals & Biotech
CLN	CHF 7.10	-5.5%	-18.8%	CHF 2.3b	CHF 8.57	0.6	46.2%	5.9%	Materials
DEZ	CHF 8.19	-3.9%	n/a	CHF 1.3b	CHF 12.17	15.6	28.4%	2.1%	Capital Goods
PEAN	CHF 4.28	-0.2%	-39.7%	CHF 238.1m	CHF 7.87	1.8	104.4%	0%	Real Estate Management and Development
KOMN	CHF 45.45	9.1%	-53.9%	CHF 232.9m	CHF 62.28	0.4	75.3%	0%	Capital Goods
ZEHN	CHF 62.30	-0.3%	-8.7%	CHF 692.5m	CHF 85.24	16.2	13.3%	2.2%	Capital Goods
ZEHNE	CHF 54.60	-1.3%	5.6%	CHF 603.2m	CHF 80.77	11.6	6.7%	3.3%	Capital Goods
000461893	CHF 300.00	0%	0%	CHF 100.1b	CHF 406.33	14.0	12.2%	3.7%	Food, Beverage & Tobacco
ACA	CHF 11.72	0%	0%	CHF 40.4b	CHF 14.61	0.6	3.7%	7.9%	Banks
RIO	CHF 71.33	0%	0%	CHF 85.2b	CHF 84.97	9.6	0.8%	6.8%	Materials
DAL	CHF 59.75	0%	0%	CHF 43.4b	CHF 73.16	8.7	-0.7%	1.1%	Transportation
BSX	CHF 34.75	-5.0%	n/a	CHF 63.4b	CHF 60.53	18.0	9.9%	n/a	Healthcare
BMW	CHF 53.98	-4.4%	-26.2%	CHF 35.4b	CHF 70.95	5.2	2.7%	7.6%	Automobiles
TECN	CHF 175.60	12.8%	7.1%	CHF 2.2b	CHF 171.98	2.5	50.0%	1.7%	Pharmaceuticals & Biotech
GF	CHF 43.06	0.9%	-32.6%	CHF 3.5b	CHF 56.50	18.1	19.5%	3.1%	Capital Goods
SUN	CHF 133.00	-4.5%	-6.3%	CHF 4.5b	CHF 184.60	15.3	9.9%	3.6%	Capital Goods
BCHN	CHF 473.50	-3.7%	-28.8%	CHF 1.6b	CHF 604.33	14.5	1.6%	3.8%	Capital Goods
AMS	CHF 16.32	-12.8%	42.4%	CHF 1.6b	CHF 15.90	0.5	62.6%	0%	Semiconductors
TTK	CHF 2.12	-2.8%	n/a	CHF 145.0m	CHF 4.44	0.2	108.2%	0%	Commercial Services
DWNI	CHF 16.94	0.1%	n/a	CHF 7.3b	CHF 18.47	6.8	11.2%	0.2%	Real Estate Management and Development
PUM	CHF 24.11	2.1%	n/a	CHF 4.0b	CHF 26.17	0.6	81.7%	n/a	Consumer Durables

Potentially Undervalued Companies